MTOR and ovarian carcinoma: Immunohistochemical staining revealed that the protein levels of the ITGB2 signaling pathway (PI3K-AKT-mTOR) were significantly higher in ovarian cancer tissues than in normal ovarian tissues (Figure 1A–1D).